micro-community-banner
 
  • Saved

1yr
When not hitting your sales target is ‘the end of the world’: Examining the effects of rational emotive behaviour therapy on the irrational beliefs and emotional reactivity of UK-based sales professionals

When not hitting your sales target is ‘the end of the world’: Examining the effects of rational emotive behaviour therapy on the irrational beliefs and emotional reactivity of UK-based sales professionals

Source : https://pubmed.ncbi.nlm.nih.gov/38414157/

Against the backdrop of the COVID-19 pandemic, workplace wellbeing is a key priority for employers. Severe market and health conditions continue to bring inevitable problems that could be reduced with...

Results indicate that those in the REBT group reported significant reductions in irrational beliefs and emotional reactivity, whilst those in the control group reported no such changes. It is recommended that future research studies consider utilizing a mixed methods design and focus on a strategic collaboration of organisational and...

  • Saved

1yr
ASCO 2024: Pioneering Advances and Future Directions in Oncology

The ASCO 2024 conference was a landmark event, drawing 45,000 registrants and presenting over 5,000 abstracts on cutting-edge advances and research in Clinical Oncology. The emphasis on patient-centric approaches, blending high-tech and high-touch care, underscored the commitment to improving patient outcomes and experiences.

  • Saved

1yr
American Society of Clinical Oncology Annual Meeting

The American Society of Clinical Oncology (ASCO) Annual Meeting is taking place in Chicago from May 3 through June 4, 2024. We summarized some research and presentations on RET-positive and other cancers, including a peek into the pipeline of treatments for RET-positive non-small cell lung cancer (NSCLC). Click above to learn more.

  • Saved

1yr
American Society of Clinical Oncology Annual Meeting

The American Society of Clinical Oncology (ASCO) Annual Meeting is taking place in Chicago from May 31 through June 4, 2024. The five-day meeting is packed with the latest information on the diagnosis, treatment, and prevention of all types of cancer, including rearranged during transfection (RET)-positive cancers.

  • Saved

1yr
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer

RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer

Source : https://pubmed.ncbi.nlm.nih.gov/38754058/

Altogether, this study provides a detailed genomic characterization of patients with MTC of Indian origin, highlighting the possible utility of targeted therapies in this disease.

Mutational landscape analysis showed expected RET mutations in 50% of the cases studied.